ResearcherNashville VA Medical CenterNo recent work listed

Maureen A. Gannon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3287-8101; OpenAlex author ID A5049426852. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2014: 1 paper

Papers 1

Loss of HNF6 expression correlates with human pancreatic cancer progression. Last author DOI 10.1038/labinvest.2014.47 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chanjuan Shi · 1 shared paper, 2014 · strength 0.04
- Paper Loss of HNF6 expression correlates with human pancreatic cancer progression. DOI 10.1038/labinvest.2014.47 ↗
Kelly R. Pekala · 1 shared paper, 2014 · strength 0.04
- Paper Loss of HNF6 expression correlates with human pancreatic cancer progression. DOI 10.1038/labinvest.2014.47 ↗
Anna L. Means · 1 shared paper, 2014 · strength 0.04
- Paper Loss of HNF6 expression correlates with human pancreatic cancer progression. DOI 10.1038/labinvest.2014.47 ↗
Nipun B. Merchant · 1 shared paper, 2014 · strength 0.04
- Paper Loss of HNF6 expression correlates with human pancreatic cancer progression. DOI 10.1038/labinvest.2014.47 ↗
Anirban Maitra · 1 shared paper, 2014 · strength 0.04
- Paper Loss of HNF6 expression correlates with human pancreatic cancer progression. DOI 10.1038/labinvest.2014.47 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.